FMI Microneedle Drug Delivery Systems Market size and | Page 5

Microneedle Drug Delivery Systems Market
Most microneedle formulate biomolecules, such as vaccine antigens in the dry state, will reduce the
issues related to cold chain. Needle stick injuries also will be avoided. Accordingly, the potential impact of
microneedle research and ultimate commercialization is growing. Once vaccine products are accepted by
regulators, healthcare providers and patients, other microneedle-based products for everyday patient
and consumer use will become widely used to the benefit of the pharmaceutical, medical devices and
cosmetics industries and patients worldwide.
With growing interest in alternative routes of drug administration transdermal and intradermal drug
delivery systems, it is expected to drive the growth of microneedle drug delivery systems market. The
industry is on the threshold of bringing into commercial production a new generation of therapies and
delivery systems.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2750
On the basis of regional presence, the global microneedle drug delivery systems market is segmented
into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America is expected to lead the global microneedle drug delivery systems market in terms of value
due to high adoption rate through 2024. Europe is expected to be the second largest market for
microneedle drug delivery systems market. Among the European countries, Germany is anticipated to be
the significant contributor in the region for microneedle drug delivery systems market. Asia Pacific and
Latin America are projected to be the fastest growing regions. Middle East & Africa would witness
relatively slower growth in microneedle drug delivery systems market during the forecast period.
©2015 Future Market Insights, All Rights Reserved
5